Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 13 results.
User Information
Export Records
  1. 1.   Design, synthesis, and biological evaluation of water-soluble amino acid prodrug conjugates derived from combretastatin, dihydronaphthalene, and benzosuberene-based parent vascular disrupting agents
  2. Devkota, L.; Lin, C. M.; Strecker, T. E.; Wang, Y.; Tidmore, J. K.; Chen, Z.; Guddneppanavar, R.; Jelinek, C. J.; Lopez, R.; Liu, L.; Hamel, E.; Mason, R. P.; Chaplin, D. J.; Trawick, M. L.; Pinney, K. G.
  3. Bioorganic & Medicinal Chemistry. 2016, 1-Mar; 24(5): 938-56.
  1. 2.   Dual role of ionic liquids as phase transfer catalyst and solvent for glycosidation reactions
  2. Kumar, V.; Talisman, I. J.; Bukhari, O.; Razzaghy, J.; Malhotra, S. V.
  3. Rsc Advances. 2011, Dec 7; 1(9): 1721-1727.
  1. 3.   Hofmeister Series Salts Enhance Purification of Plasmid DNA by Non-Ionic Detergents
  2. Lezin, G.; Kuehn, M. R.; Brunelli, L.
  3. Biotechnology and Bioengineering. 2011, Aug; 108(8): 1872-1882.
  1. 4.   Application of Halide Molten Salts as Novel Reaction Media for O-Glycosidic Bond Formation
  2. Kumar, V.; Talisman, I. J.; Malhotra, S. V.
  3. European Journal of Organic Chemistry. 2010, Jun; (18): 3377-3381.
  1. 5.   Synthesis and applications of novel bis(ammonium) chiral ionic liquids derived from isomannide
  2. Kumar, V.; Olsen, C. E.; Schaffer, S. J. C.; Parmar, V. S.; Malhotra, S. V.
  3. Organic Letters. 2007, Sep; 9(20): 3905-3908.
  1. 6.   Antitumor agents. Part 236: Synthesis of water-soluble colchicine derivatives
  2. Nakagawa-Goto, K.; Chen, C. X.; Hamel, E.; Wu, C. C.; Bastow, K. F.; Brossi, A.; Lee, K. H.
  3. Bioorganic & Medicinal Chemistry Letters. 2005, JAN 3; 15(1): 235-238.
  1. 7.   Antitumo agents 238. Anti-tubulin and in vitro cytotoxic effects of N-substituted allocolchicinoids
  2. Nakagawa-Goto, K.; Jung, M. K.; Hamel, E.; Wu, C. C.; Bastow, K. F.; Brossi, A.; Ohta, S.; Lee, K. H.
  3. Heterocycles. 2005 65(3): 541-550.
  1. 8.   Antineoplastic agents. 499. Synthesis of hystatin 2 and related 1H-benzo[de][1,6]-naphthyridinium salts from aaptamine
  2. Pettit, G. R.; Hoffmann, H.; Herald, D. L.; Blumberg, P. M.; Hamel, E.; Schmidt, J. M.; Chang, Y.; Pettit, R. K.; Lewin, N. E.; Pearce, L. V.
  3. Journal of Medicinal Chemistry. 2004 47(7): 1775-1782.
  1. 9.   Excitations, optical absorption spectra, and optical excitonic gaps of heterofullerenes. 1. C-60, C59N+, and C48N12: Theory and experiment
  2. Xie, R. H.; Bryant, G. W.; Sun, G. Y.; Nicklaus, M. C.; Heringer, D.; Frauenheim, T.; Manaa, M. R.; Smith, V. H.; Araki, Y.; Ito, O.
  3. Journal of Chemical Physics. 2004 120(11): 5133-5147.
  1. 10.   Synthesis of new dihydroindeno 1,2-c isoquinoline and indenoisoquinolinium chloride topoisomerase I inhibitors having high in vivo anticancer activity in the hollow fiber animal model
  2. Jayaraman, M.; Fox, B. M.; Hollingshead, M.; Kohlhagen, G.; Pommier, Y.; Cushman, M.
  3. Journal of Medicinal Chemistry. 2002 45(1): 242-249.
  1. 12.   Antineoplastic agents 463. Synthesis of combretastatin A-3 diphosphate prodrugs
  2. Pettit, G. R.; Minardi, M. D.; Boyd, M. R.; Pettit, R. K.
  3. Anti-Cancer Drug Design. 2000 15(6): 397-403.
  1. 13.   Preclinical Evaluation of 9-Chloro-2-Methylellipticinium Acetate Alone and in Combination With Conventional Anticancer Drugs For the Treatment of Human Brain Tumor Xenografts
  2. Arguello, F.; Alexander, M. A.; Greene, J. F.; Stinson, S. F.; Jorden, J. L.; Smith, E. M.; Kalavar, N. T.; Alvord, W. G.; Klabansky, R. L.; Sausville, E. A.
  3. Journal of Cancer Research and Clinical Oncology. 1998 124(1): 19-26.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel